Teclistamab in Relapsed Refractory Multiple Myeloma Patients on Dialysis: A French Experience

被引：5

作者：

Lachenal, Florence ^{[1
]}

Lebreton, Pierre ^{[2
]}

Bouillie, Sylvie ^{[3
]}

Matteo, Gian ^{[4
]}

Aftisse, Hassina ^{[5
]}

Pascal, Laurent ^{[6
]}

Montes, Lydia ^{[7
]}

Macro, Margaret ^{[8
]}

Vignon, Marguerite ^{[9
]}

Harel, Stephanie ^{[10
]}

Fernandez, Mariana ^{[11
]}

Louni, Chanaz ^{[12
]}

Huart, Antoine ^{[13
]}

Perrot, Aurore ^{[14
]}

机构：

[1] GHND Grp Hosp Nord Dauphine, Bourgoin Jallieu, France

[2] Grp Hosp Havre, Le Havre, France

[3] Janssen, Issy Les Moulineaux, France

[4] CH Chambery, Dept Hematol, Chambery, France

[5] Ctr Hosp St Quentin, St Quentin en Yvelines, France

[6] Hop St Vincent De Paul, Lille, France

[7] Ctr Hosp Univ Amiens Picardie, Serv Hematol, Amiens, France

[8] Hop Cote Nacre, Caen, France

[9] Hop Cochin, AP HP, Hematol Clin, Paris, France

[10] St Louis Hosp, Paris, France

[11] Janssen Cilag Spain, Madrid, Spain

[12] IFM, Paris, France

[13] CHU Toulouse Rangueil, Dept Nephrol & Transplantat, Toulouse, France

[14] Univ Toulouse, CHU Toulouse, IUCT O, UPS,Serv Hematol, Toulouse, France

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-180660

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Autologous retransplantation in patients with relapsed or refractory multiple myeloma - experience of two centers
Karp, S.
Teipel, R.
Zolnowski, D.
Trautmann-Grill, K.
Pannach, M.
Zinn, J.
Roellig, C.
Haenel, A.
Herbst, R.
Kroschinsky, F.
Morgner, A.
von Bonin, M.
Bornhaeuser, M.
Haenel, M.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 236 - 236
[42] Teclistamab Induces Favorable Responses in Patients with Relapsed and Refractory Multiple Myeloma after Prior BCMA-Directed Therapy
Grajales-Cruz, Ariel F.
Castaneda, Omar
Hansen, Doris K.
Vazquez-Martinez, Mariola A.
Blue, Brandon
Khadka, Sushmita
Liu, Hien
Ochoa-Bayona, Jose L.
Freeman, Ciara Louise L.
Locke, Frederick L.
Nishihori, Taiga
Shain, Kenneth
Baz, Rachid
Alsina, Melissa
BLOOD, 2023, 142
[43] A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment
Habib, Alma
Khan, Abdullah Mohammad
Laharwal, Mehak M.
Mewawalla, Prerna
Mckenna, Marshall
Tiger, Yun Kyoung
Shaikh, Hira
Strouse, Christopher
Green, Kimberly M.
Davis, James A.
Hashmi, Hamza
Snyder, Jordan
Mahmoudjafari, Zahra
Mushtaq, Muhammad Umair
Ahmed, Nausheen
Abdallah, Al-Ola
Atrash, Shebli
Paul, Barry
Friend, Reed
BLOOD, 2024, 144 : 7037 - 7038
[44] Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies
Firestone, Ross
Shekarkhand, Tala
Patel, Dhwani
Tan, Carlyn Rose Co
Hultcrantz, Malin
Lesokhin, Alexander M.
Mailankody, Sham
Hassoun, Hani
Shah, Urvi A.
Korde, Neha
Maclachlan, Kylee
Landau, Heather Jolie
Scordo, Michael
Chung, David J.
Shah, Gunjan L.
Lahoud, Oscar Boutros
Giralt, Sergio
Usmani, Saad Zafar
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[45] Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1
Xin Miao
Liviawati S. Wu
Shun Xin Wang Lin
Yan Xu
Yang Chen
Yuki Iwaki
Rachel Kobos
Tara Stephenson
Kristy Kemmerer
Clarissa M. Uhlar
Arnob Banerjee
Jenna D. Goldberg
Danielle Trancucci
Amit Apte
Raluca Verona
Lixia Pei
Rachit Desai
Kathleen Hickey
Yaming Su
Daniele Ouellet
Mahesh N. Samtani
Yue Guo
Alfred L. Garfall
Amrita Krishnan
Saad Z. Usmani
Honghui Zhou
Suzette Girgis
Targeted Oncology, 2023, 18 : 667 - 684
[46] Estimating direct costs of care for patients with relapsed or refractory multiple myeloma in french hospitals
Armoiry, X.
Fagnani, F.
Benboubker, L.
Facon, T.
Fermand, J.
Hulin, C.
Moreau, P.
Aulagner, G.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[47] POMALIDOMIDE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): EXPERIENCE CENTER
Cuesta Garcia, A.
HAEMATOLOGICA, 2015, 100 : 104 - 104
[48] Real-World Clinical Outcomes of Teclistamab and Talquetamab in Relapsed/Refractory Multiple Myeloma (RRMM): A UK Single-Centre Experience
Feixas, Pablo Tenorio
Cox, Catrin
Peer, Xavier
Cuthill, Kirsty
Benjamin, Reuben
Gunawan, Arief
Cuadrado, Maria
de Farias, Madson Correia
Jones, John
Shin, Jin-Sup
Batool, Asma
Bowcock, Stella
Omer, Musab
Tawde, Prachi
Bailey, Katharine
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S92 - S92
[49] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
Stepanovic, Adam
Abonour, Rafat
Abu Zaid, Mohammad
Farag, Sherif
Lee, Kelvin P.
Suvannasankha, Attaya
BLOOD, 2023, 142
[50] Evaluation of Teclistamab in BCMA-Directed Therapy Exposed Versus Naive in Relapsed/Refractory Multiple Myeloma
Snyder, Jordan
Graf, Kevin
Davis, James A.
Mckenna, Marshall
Tiger, Yun Kyoung
Laharwal, Mehak M.
Mewawalla, Prerna
Alkharabsheh, Omar
Hashmi, Hamza
Shaikh, Hira
Lochner, Jonathan
Chang, Darryl
Atrash, Shebli
Habib, Alma
Venkatesh, Priyanka
Mahmoudjafari, Zahra
Ahmed, Nausheen
Mushtaq, Muhammad Umair
Abdallah, Al-Ola
Green, Kimberly M.
Khan, Abdullah Mohammad
BLOOD, 2024, 144 : 24117 - 24118

← 1 2 3 4 5 →